Publications

European journal of cancer (Oxford, England : 1990)

The SHERPA trial: A phase I study combining SHP2 inhibitor RMC-4630 and ERK inhibitor LY3214996 in patients with KRAS-mutant pancreatic, non-small cell lung and colorectal cancer.

18-06-2026

The Lancet. Oncology

Development and validation of artificial intelligence-assisted volumetric response criteria in pleural mesothelioma (ARTIMES): a retrospective, multicohort, multicentre study.

17-06-2026

Nature communications

Tremelimumab with or without durvalumab in combination with paclitaxel in metastatic urothelial cancer: phase I/II ICRA trial.

17-06-2026

European urology

Re: Neoadjuvant Sacituzumab Govitecan plus Pembrolizumab, Followed by Adjuvant Pembrolizumab, in Patients with Muscle-invasive Bladder Cancer (SURE-02): A Single-arm, Phase 2 Study.

17-06-2026

International journal of cancer

Toward a validated European instrument to measure the socioeconomic impact of cancer.

15-06-2026

Journal of the National Cancer Institute

Temporal Trends of Subsequent Malignant Neoplasms in Childhood Cancer Survivors and the Impact of Treatment Changes: A DCCSS-LATER Study.

12-06-2026

BMJ open

Effect of yoga on musculoskeletal complaints in women during endocrine treatment for breast cancer: protocol of the randomised controlled COBRA trial.

09-06-2026

Journal of the National Cancer Institute

Change in body mass index and physical activity and postmenopausal breast cancer risk in a cohort of Dutch nurses.

05-06-2026

BJC reports

Contralateral breast cancer risks for BRCA1, BRCA2, PALB2, CHEK2, and ATM pathogenic variant carriers in two large cohort studies.

03-06-2026

American journal of physical medicine & rehabilitation

Assessing Cardiorespiratory Fitness in Clinical Rehabilitation: Validity of Field Exercise Tests and Patient-Reported Questionnaires.

02-06-2026

Journal of cancer survivorship : research and practice

Patient-reported outcomes in cancer survivorship: insights from two decades of population-based PROFILES registry research.

01-06-2026

European urology oncology

Update of the EORTC Health-related Quality of Life Modules for Bladder Cancer: Phase 1-2 of the Development Process.

01-06-2026

European journal of nuclear medicine and molecular imaging

3D intraabdominal molecular imaging of primary prostate cancer, a hybrid approach that utilizes the robotic vision and dexterity.

01-06-2026

Life science alliance

Histone methyltransferase DOT1L differentially affects the development of dendritic cell subsets.

01-06-2026

Journal of cancer survivorship : research and practice

Concordance between late effects reported by physicians and patients in a cohort of long-term Hodgkin lymphoma survivors: an analysis of data from nine consecutive EORTC-LYSA trials.

01-06-2026

European journal of nuclear medicine and molecular imaging

Flexible intraoperative detectors for robotic and laparoscopic image-guided surgery: a systematic review.

01-06-2026

British journal of clinical pharmacology

Clinical response to capecitabine in a DPYD*2A homozygous patient: Case report and therapeutic guidance.

01-06-2026

Breast (Edinburgh, Scotland)

Immunohistochemical biomarkers to predict adjuvant chemotherapy response in patients with early breast cancer in the MATADOR trial (BOOG 2005-02).

01-06-2026

Journal of nuclear medicine : official publication, Society of Nuclear Medicine

Actionable Feedback on Signal-to-Background Ratios During Drop-in Radioguided Surgery.

01-06-2026

Mechanisms of ageing and development

Antiretroviral raltegravir, a selective human immunodeficiency virus type 1 integrase inhibitor, shows anti-Alzheimer's potential against amyloid-beta_1-42-induced neurodegeneration.

01-06-2026

JAMA oncology

Pretreatment MRI as a Prognostic Factor After Radical Prostatectomy: A Systematic Review and Meta-Analysis.

01-06-2026

British journal of clinical pharmacology

Population pharmacokinetics and dose-response relationships of mitoxantrone in children with acute myeloid leukaemia.

01-06-2026

JCO precision oncology

Pharmacokinetics of 5-Fluorouracil in Patients Treated With Capecitabine Carrying the c.1236G>A DPYD Variant Allele.

01-06-2026

British journal of cancer

Safety and efficacy of lapatinib, binimetinib, and vinorelbine for RAS mutant metastatic colorectal cancer: results of the RASTRIC Phase I/II trial.

01-06-2026

Cancer treatment reviews

Progress toward personalized management of stage II/III triple negative breast cancer.

01-06-2026

Cell research

Social status impacts T-cell responses through synapse strength in the prefrontal cortex.

01-06-2026

Clinical cancer research : an official journal of the American Association for Cancer Research

Immunity, Age, and Luminal Breast Cancer: Understanding the Holy Trinity.

01-06-2026

Cancer treatment reviews

Central nervous system and leptomeningeal metastases in patients with HER2-positive breast cancer: A comprehensive review and therapeutic algorithm proposal.

01-06-2026

The Annals of otology, rhinology, and laryngology

A Prospective Multicenter Observational Study Investigating the Concordance Between Patient-Reported Hearing Loss and Commonly Used Ototoxicity Grading Systems in Patients Treated with Platinum-Based Chemotherapy.

01-06-2026

Journal of cancer survivorship : research and practice

Perspectives of patients, partners, primary and hospital-based health care professionals on living with advanced cancer and systemic treatment.

01-06-2026

ESMO real world data and digital oncology

Validating large language model-assisted data extraction from clinical notes.

01-06-2026

PloS one

Choice and impact of EQ-5D-5L value set in cost-utility analyses alongside multinational trials: Insights from PREFERABLE-EFFECT and CONVINCE.

01-06-2026

Academic radiology

CT Staging of Colon Cancer: Reproducibility and Pathology Association in a Multicenter Study.

01-06-2026

Journal of robotic surgery

Eye-hand coordination during robotic prostate cancer surgery - how surgical vision reflects on instrument kinematics and vice versa.

28-05-2026

Cancer communications (London, England)

Sex Impacts Progression-Free Survival of Alectinib through Drug Exposure in Patients with ALK-Positive Non-Small Cell Lung Cancer.

25-05-2026

Cancer chemotherapy and pharmacology

Transfer of trastuzumab and pertuzumab into human breast milk: a case report.

20-05-2026

European radiology

Quality over quantity: biopsy-anchored CT radiogenomics models outperform all-lesion training in a multi-tumour cohort despite a smaller sample size.

16-05-2026

BMC cancer

Hepatic arterial infusion pump chemotherapy combined with systemic therapy versus systemic therapy alone as induction treatment for initially unresectable colorectal liver metastases: a study protocol of the randomised controlled trial - PUMP-IT RCT.

16-05-2026

European journal of cancer (Oxford, England : 1990)

From prediction to precision: Biomarker discovery and predictive modeling for personalized immune checkpoint blockade therapy.

15-05-2026

Clinical cancer research : an official journal of the American Association for Cancer Research

PI3K Inhibition in Combination with Tamoxifen in Patients with Metastatic HR+/HER2- Breast Cancer: Clinical and Circulating Tumor DNA Results.

15-05-2026

European radiology experimental

MRI radiomics predicting cribriform growth informs active surveillance decision in intermediate-risk prostate cancer.

13-05-2026

Journal for immunotherapy of cancer

Local immunotherapy in the neoadjuvant treatment of cancer: optimizing efficacy while limiting toxicity?

13-05-2026

Proceedings of the National Academy of Sciences of the United States of America

Acupuncture does not work and has no place in science-based medicine.

12-05-2026

Nature communications

E-cadherin inactivation shapes tumor microenvironment specificities in invasive lobular breast cancer.

12-05-2026

Genome medicine

The contribution of rare germline variants to the immune landscape of breast cancer.

09-05-2026

Cancers

Recruitment Strategies, Response Rates, and Non-Response Patterns in a Nationwide Registry-Based PRO Survey of Cancer Survivors and the General Population: The SURV-ICE Cohort.

08-05-2026

BMJ open

Dose dE-eScalaTion IN prostATe radIOtherapy usiNg an MR-Linac in 2 Fractions (DESTINATION 2): protocol for a randomised, phase II/R-IDEAL2b trial.

07-05-2026

NPJ breast cancer

Enabling DCIS subtyping: leveraging foundation models for robust grading and molecular biomarker scoring.

06-05-2026

Breast cancer research and treatment

Long-term outcomes in triple-negative breast cancer after a pathologic complete response: does the type of neoadjuvant therapy matter?

05-05-2026

Journal of cancer survivorship : research and practice

Long-term cognitive function after treatment with immune checkpoint inhibition for melanoma.

05-05-2026

The SHERPA trial: A phase I study combining SHP2 inhibitor RMC-4630 and ERK inhibitor LY3214996 in patients with KRAS-mutant pancreatic, non-small cell lung and colorectal cancer.

Development and validation of artificial intelligence-assisted volumetric response criteria in pleural mesothelioma (ARTIMES): a retrospective, multicohort, multicentre study.

Tremelimumab with or without durvalumab in combination with paclitaxel in metastatic urothelial cancer: phase I/II ICRA trial.

Re: Neoadjuvant Sacituzumab Govitecan plus Pembrolizumab, Followed by Adjuvant Pembrolizumab, in Patients with Muscle-invasive Bladder Cancer (SURE-02): A Single-arm, Phase 2 Study.

Toward a validated European instrument to measure the socioeconomic impact of cancer.

Temporal Trends of Subsequent Malignant Neoplasms in Childhood Cancer Survivors and the Impact of Treatment Changes: A DCCSS-LATER Study.

Effect of yoga on musculoskeletal complaints in women during endocrine treatment for breast cancer: protocol of the randomised controlled COBRA trial.

Change in body mass index and physical activity and postmenopausal breast cancer risk in a cohort of Dutch nurses.

Contralateral breast cancer risks for BRCA1, BRCA2, PALB2, CHEK2, and ATM pathogenic variant carriers in two large cohort studies.

Assessing Cardiorespiratory Fitness in Clinical Rehabilitation: Validity of Field Exercise Tests and Patient-Reported Questionnaires.

Patient-reported outcomes in cancer survivorship: insights from two decades of population-based PROFILES registry research.

Update of the EORTC Health-related Quality of Life Modules for Bladder Cancer: Phase 1-2 of the Development Process.

3D intraabdominal molecular imaging of primary prostate cancer, a hybrid approach that utilizes the robotic vision and dexterity.

Histone methyltransferase DOT1L differentially affects the development of dendritic cell subsets.

Concordance between late effects reported by physicians and patients in a cohort of long-term Hodgkin lymphoma survivors: an analysis of data from nine consecutive EORTC-LYSA trials.

Flexible intraoperative detectors for robotic and laparoscopic image-guided surgery: a systematic review.

Clinical response to capecitabine in a DPYD*2A homozygous patient: Case report and therapeutic guidance.

Immunohistochemical biomarkers to predict adjuvant chemotherapy response in patients with early breast cancer in the MATADOR trial (BOOG 2005-02).

Actionable Feedback on Signal-to-Background Ratios During Drop-in Radioguided Surgery.

Antiretroviral raltegravir, a selective human immunodeficiency virus type 1 integrase inhibitor, shows anti-Alzheimer's potential against amyloid-beta1-42-induced neurodegeneration.

Pretreatment MRI as a Prognostic Factor After Radical Prostatectomy: A Systematic Review and Meta-Analysis.

Population pharmacokinetics and dose-response relationships of mitoxantrone in children with acute myeloid leukaemia.

Pharmacokinetics of 5-Fluorouracil in Patients Treated With Capecitabine Carrying the c.1236G>A DPYD Variant Allele.

Safety and efficacy of lapatinib, binimetinib, and vinorelbine for RAS mutant metastatic colorectal cancer: results of the RASTRIC Phase I/II trial.

Progress toward personalized management of stage II/III triple negative breast cancer.

Social status impacts T-cell responses through synapse strength in the prefrontal cortex.

Immunity, Age, and Luminal Breast Cancer: Understanding the Holy Trinity.

Central nervous system and leptomeningeal metastases in patients with HER2-positive breast cancer: A comprehensive review and therapeutic algorithm proposal.

A Prospective Multicenter Observational Study Investigating the Concordance Between Patient-Reported Hearing Loss and Commonly Used Ototoxicity Grading Systems in Patients Treated with Platinum-Based Chemotherapy.

Perspectives of patients, partners, primary and hospital-based health care professionals on living with advanced cancer and systemic treatment.

Validating large language model-assisted data extraction from clinical notes.

Choice and impact of EQ-5D-5L value set in cost-utility analyses alongside multinational trials: Insights from PREFERABLE-EFFECT and CONVINCE.

CT Staging of Colon Cancer: Reproducibility and Pathology Association in a Multicenter Study.

Eye-hand coordination during robotic prostate cancer surgery - how surgical vision reflects on instrument kinematics and vice versa.

Sex Impacts Progression-Free Survival of Alectinib through Drug Exposure in Patients with ALK-Positive Non-Small Cell Lung Cancer.

Transfer of trastuzumab and pertuzumab into human breast milk: a case report.

Quality over quantity: biopsy-anchored CT radiogenomics models outperform all-lesion training in a multi-tumour cohort despite a smaller sample size.

Hepatic arterial infusion pump chemotherapy combined with systemic therapy versus systemic therapy alone as induction treatment for initially unresectable colorectal liver metastases: a study protocol of the randomised controlled trial - PUMP-IT RCT.

From prediction to precision: Biomarker discovery and predictive modeling for personalized immune checkpoint blockade therapy.

PI3K Inhibition in Combination with Tamoxifen in Patients with Metastatic HR+/HER2- Breast Cancer: Clinical and Circulating Tumor DNA Results.

MRI radiomics predicting cribriform growth informs active surveillance decision in intermediate-risk prostate cancer.

Local immunotherapy in the neoadjuvant treatment of cancer: optimizing efficacy while limiting toxicity?

Acupuncture does not work and has no place in science-based medicine.

E-cadherin inactivation shapes tumor microenvironment specificities in invasive lobular breast cancer.

The contribution of rare germline variants to the immune landscape of breast cancer.

Recruitment Strategies, Response Rates, and Non-Response Patterns in a Nationwide Registry-Based PRO Survey of Cancer Survivors and the General Population: The SURV-ICE Cohort.

Dose dE-eScalaTion IN prostATe radIOtherapy usiNg an MR-Linac in 2 Fractions (DESTINATION 2): protocol for a randomised, phase II/R-IDEAL2b trial.

Enabling DCIS subtyping: leveraging foundation models for robust grading and molecular biomarker scoring.

Long-term outcomes in triple-negative breast cancer after a pathologic complete response: does the type of neoadjuvant therapy matter?

Long-term cognitive function after treatment with immune checkpoint inhibition for melanoma.

This site uses cookies

Antiretroviral raltegravir, a selective human immunodeficiency virus type 1 integrase inhibitor, shows anti-Alzheimer's potential against amyloid-beta_1-42-induced neurodegeneration.